Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Anaptys (Nasdaq: ANAB) announced that Daniel Faga, president and CEO, will participate in a fireside chat at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Anaptys (Nasdaq: ANAB) announced that Daniel Faga, president and CEO, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on Wednesday, May 6, 2026 at 1:30pm ET. Registration is available via the conference website.
Details
News Market Reaction – ANAB
On May 5, the first trading day after this news, ANAB closed 0.72% below the previous close.
Data tracked by StockTitan Argus for the May 5 session.
Key Figures
- Conference date
- May 6, 2026
- H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
- Fireside chat time
- 1:30pm ET
- Scheduled start time for ANAB fireside chat
- Conference edition
- 2nd Annual
- H.C. Wainwright Royalty Company Virtual Conference
Historical Context
-
NEJM Evidence publication and BLA status for imsidolimab in GPP.
-
Court ruling in favor of Anaptys dismissing Tesaro anticipatory breach claim.
-
Completion of First Tracks spin-off and transition to royalty-focused model.
-
First Tracks private placement funding clinical programs and spin-off launch.
-
Board approval of First Tracks spin-off and TRAX share distribution terms.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Daniel Faga, president and chief executive officer of Anaptys, is scheduled to participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on Wednesday, May 6, 2026. The fireside chat is scheduled to begin at 1:30pm ET.
To register for the conference, please visit https://hcwevents.com/royalty-company-conference.
About Anaptys
Anaptys manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, with a focus on protecting and returning the value of its royalties to shareholders. To learn more, visit www.AnaptysBio.com or follow us on LinkedIn.
Contact:
Anaptys Investor Relations
investors@anaptysbio.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.